4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-102326
Director sold 134,261 shares at an average $45.03 ($6,045,783)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-08-28 | Sale 10b5-1 | −16,386 | $44.41 | $727,702 | 549,175 | I |
| Kersten Dirk Director | 2024-08-28 | Sale 10b5-1 | −61,467 | $44.94 | $2,762,327 | 487,708 | I |
| Kersten Dirk Director | 2024-08-29 | Sale 10b5-1 | −45,640 | $45.19 | $2,062,472 | 442,068 | I |
| Kersten Dirk Director | 2024-08-29 | Sale 10b5-1 | −10,768 | $45.81 | $493,282 | 431,300 | I |
| Open-market sales · 134,261 sh · avg $45.03 · $6,045,783 | |||||||
Loading xslF345X05/ownership.xml…